BNET Industries
Last Fiscal Year Sales:$1.9B
- Private
- US
Dow Jones Description
Chiron Corporation, based in Emeryville, CA, deals in human healthcare products, offering blood safety products, vaccines, and a range of therapeutic products. The company offers more than 30 vaccines for flu, meningococcal, and pediatric vaccines. Some of its products are Procleix(R) HIV-1/HCV Assay, RIBA(R) tests, DTP vaccine and Oral polio vaccine, TOBI(R). It develops and markets a range of blood safety products used by blood banks and in transfusions. Founded in 1981, the company has revenue of $1.9 billion and employs about 5,500 people. In April 2006 the company merged with Novartis AG (NYSE:NVS) when Novartis acquired all Chiron shares it didn't already own for $48.00 per share in cash.
President, Vaccines
Daniel B. SolandNumber of Employees 5,500
Contact Information
4560 Horton St
Emeryville, California 94608-2916
(510) 655-8730
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
News & Analysis
Filter by
chiron corp. - All News and Analysis
Swivelhead spindle VMC designed fop single setups—Chiron America
With seven CNC-controlled axes, Chiron's FZ 12K S with swivelhead offers various machining options in one setup, from the bar. Capable of high-precision, automated, six-side machining, the VMC is suited for machining watch casings, medical parts or hydraulic components. Medical applications for this machine include orthopedic devices, such as larger...
Show to feature bomb suspect
Daniel Andreas San Diego, an animal rights activist and federal fugitive wanted in connection with two East Bay bombings in 2003, will be featured again this weekend on Fox Network's "America's Most Wanted." San Diego's case first was aired on the television program in March 2004, and...
TV crime show to feature Chiron bombing suspect
Daniel Andreas San Diego, an animal rights activist and federal fugitive wanted in connection with two East Bay bombings in 2003, will be featured again this weekend on Fox Network's "America's Most Wanted." San Diego's case first was aired on the television program in 2004, and again...
TV crime show features Chiron bombing suspect
Daniel Andreas San Diego, an animal rights activist and federal fugitive wanted in connection with two East Bay bombings in 2003, will be featured again this weekend on Fox Network's "America's Most Wanted." San Diego's case first was aired on the television program in March 2004, and...
Chiron bombing suspect featured
Daniel Andreas San Diego, an animal rights activist and federal fugitive wanted in connection with two East Bay bombings in 2003, will be featured again this weekend on Fox Network's "America's Most Wanted." San Diego's case first was aired on the television program in March 2004, and...
TV crime show to feature Chiron bombing suspect
Daniel Andreas San Diego, an animal rights activist and federal fugitive wanted in connection with two East Bay bombings in 2003, will be featured again this weekend on Fox Network's "America's Most Wanted." San Diego's case first was aired on the television program in March 2004, and...
Suspected East Bay bomber to be featured on America's Most Wanted
Daniel Andreas San Diego, an animal-rights activist and federal fugitive wanted in connection with two East Bay bombings in 2003, will be featured again this weekend on Fox Network's "America's Most Wanted." San Diego's case first was aired on the television program in March 2004, and again in...
Novartis Delivers Dynamic Sales and Earnings Growth in the First Nine Months of 2006, Reaffirms Outlook for Record Full-Year Results
-- Group continues double-digit expansion -- Nine-month net sales up 14% (+15% lc) to USD 27.0 billion on strong underlying growth and acquisition-related contributions -- Operating income rises 17%, supported by all divisions...
Former Chiron Exec Joins APT Pharmaceuticals as CEO
FOSTER CITY, Calif. -- APT Pharmaceuticals Inc. (http://www.aptbio.com) has named the former chief medical officer of Chiron BioPharmaceuticals, Stephen G. Dilly, M.B.B.S., Ph.D., as chief executive officer.
Research and Markets: A Fourth Division for Novartis under the Title Vaccines & Diagnostics, Will Be Created After the Acquisition of Chiron Corporation
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c41412) has announced the addition of Espicom Business Intelligence's Novartis Prospects to 2010 to their offering.
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Daniel B. Soland | President, Vaccines |
| Gene Walther | President |
| Jack Goldstein | President, Blood Testing |
| William G. Green | President, Blood Testing Division |
| David V. Smith | Chief Financial Officer |
| Meghan B. Leader | CIO & Vice President |
| Rino Rappuoli | Chief Scientific Officer |
| Anne Hill | Vice President, Human Resources |
| Bryan Walser | Vice President |
| Jessica Hoover | Vice President |
| John Lambert | Vice President |
| Kathelyn Steimer | Vice President, Research |
| Leone Patterson | Vice President & Controller |
| Linda Short | Vice President, Corp Resources |
| Ursula B. Bartels | General Counsel & Vice President |
| William (Bill) C. Waller | V.P. of Ethics and Compliance |
| Edward E. Penhoet | Director |
| Gilbert F. Amelio | Director |
| J. Richard Fredericks | Director |
| Paul L. Herrling | Director |
| Pierre Douaze | Director |
| Pieter J. Strijkert | Director |
| Raymund Breu | Director |
| Vaughn D. Bryson | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Denise M. O'Leary | Board of Directors |
Daniel Soland has served as Vice President, Chief Commercial Officer of ViroPharma since November 2006. He joined ViroPharma from his previous post as President of Chiron Vaccines. At Chiron, Soland was most recently responsible for managing the vaccine division to annual sales of $1 billion. Prior to Chiron, he was the president and chief executive officer of Epigenesis Pharmaceuticals, a privately held biopharmaceutical company engaged in developing drugs for use in asthma, COPD and allergic rhinitis. Prior to that, Mr. Soland spent nine years with GlaxoSmithKline as the vice president and director of worldwide marketing operations, and five years as their vice president and director of the U.S. vaccines business unit. Mr. Soland holds a Bachelor of Science degree in pharmacy from the University of Iowa, in Iowa City, IA.
| Organization | Position | Status |
|---|---|---|
| Chiron | President, Vaccines | Current |
| ViroPharma Incorporated | Chief Commercial Officer | Current |
| Phillystocks.Com | Vice President, Chief Commercial Officer | Current |
| ViroPharma Incorporated | Vice President | Current |
| Copd | Chief Executive Officer | Former |
| Epigenesis Pharmaceuticals, LLC | Chief Executive Officer | Former |
| Copd | President | Former |
| Epigenesis Pharmaceuticals, LLC | President | Former |
| Chiron | Vice President, Vaccines | Former |
| The University of Iowa | B.S. Degree In Pharmacy | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | President | Current |
| Chiron | Vice President, Commercial Development, North America and Asia Pacific | Former |
| Gen-Probe Inc. | Vice President, Global Marketing and International Sales | Former |
| Chiron | Global Head of Diagnostics | Former |
| Michigan State University | B.S. Degree In Microbiology and Immunology | Former |
| Gen-Probe Inc. | Team Member | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | President, Blood Testing | Current |
| Illumina, Inc. | Chairperson | Current |
| Solexa, Inc. | Chairperson | Current |
| Epitope, Inc. | Board of Directors | Current |
| Nanotechnology.Com | Director | Current |
| Bio-IT World, Inc. | Director | Current |
| The Hepatitis C Support Project | Board of Directors | Current |
| OraSure Technologies, Inc. | Board of Directors | Current |
| Histofreezer | Board of Directors | Current |
| Chiron | Board of Directors | Current |
| Applied Imaging Corp. | CEO | Former |
| Applied Imaging Corp. | President | Former |
| Johnson & Johnson | President | Former |
| Chiron | Interim Chief Operating Officer | Former |
| Chiron | Vice President | Former |
| Windamere Venture Partners, LLC | General Partner | Former |
| Chiron | Officer | Former |
| Applied Imaging Corp. | Chairman | Former |
| Immucor, Inc. | Board of Directors | Former |
| St. John's University | Ph.D. In Microbiology | Former |
| St. John's University | M.S. In Immunology | Former |
| Rider University | B.A. In Biology | Former |
| American Home Products Corporation | Team Member | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | President, Blood Testing Division | Current |
| Chiron | Member, Executive Committee | Current |
| Chiron | Senior Vice President | Former |
| Chiron | General Counsel | Former |
| Organization | Position | Status |
|---|---|---|
| Thoratec Corporation | Cfo & Executive Vice President | Current |
| Chiron | Chief Financial Officer | Current |
| Perlegen Sciences, Inc. | Board of Directors | Current |
| Anergen | Chief Financial Officer | Former |
| Anergen | Vice President, Finance | Former |
| Chiron | Vice President | Former |
| Chiron | Controller | Former |
| Chiron | Principal Accounting Officer | Former |
| Golden Gate University | B.A. In Economics and History | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | CIO & Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | Chief Scientific Officer | Current |
| Chiron | Vice President | Former |
| Chiron | Co-Founder of the Field of Cellular Microbiology | Former |
| Harvard Medical School | Visiting Scientist | Former |
| The Rockefeller University | Visiting Scientist | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | Vice President, Human Resources | Current |
| Baxter International Inc. | Global Vpof Human Resources for the Bioscience Division | Former |
| Baxter International Inc. | Executive | Former |
| University of Wales | Bsc Econ Degree In Industrial Relations | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | Vice President | Current |
| Chiron | Head of Corporate Business Development | Former |
| Yale Law School | J.D | Former |
| University of California | A.B | Former |
| Chiron | Member of the Law Department | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | Vice President | Current |
| Gavi | Representative | Current |
| Acambis plc | Non-Executive Director | Current |
| Cambridge Biostability Limited | Chairman | Current |
| Novavax, Inc. | Chairman | Current |
| aventis Group | Former | |
| Novavax, Inc. | Board of Directors | Current |
| Acambis plc | Board of Directors | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | Vice President, Research | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | Vice President & Controller | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | Vice President, Corp Resources | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | General Counsel & Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | V.P. of Ethics and Compliance | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Gordon and Betty Moore Foundation | President | Current |
| Renovis, Inc. | Co-Founder | Current |
| Alta Partners | Principal | Current |
| Metabolex, Inc. | Chairman of the Board | Current |
| ZymoGenetics, Inc. | Chairman | Current |
| Chimerix, Inc. | Director | Current |
| Chiron | Director | Current |
| Scynexis, Inc. | Board of Directors | Current |
| Alta Partners | Director | Current |
| ZymoGenetics, Inc. | Board of Directors | Current |
| Gordon and Betty Moore Foundation | Member of the Board of Trustees | Current |
| Chemocentryx, Inc. | Board of Directors | Current |
| Corcept Therapeutics Incorporated | Director | Current |
| National Academy of Sciences | Member | Current |
| Chiron | chief executive officer | Former |
| Chiron | president | Former |
| Chiron | Co-Founder | Former |
| University of California, Berkeley | Member Biochemistry Department | Former |
| University of California, San Diego | Fellow | Former |
| University of California | Dean of the School of Public Health | Former |
| Renovis, Inc. | Chairman of the Board of Directors | Former |
| Chiron | Vice Chairman | Former |
| University of Washington | Ph.D. In Biochemistry | Former |
| Stanford University | A.B. In Biology | Former |
| University of California | post-doctoral fellow | Former |
| Organization | Position | Status |
|---|---|---|
| Jazz Semiconductor, Inc. | CEO | Current |
| Sienna Ventures | Senior Partner | Current |
| Jazz Semiconductor, Inc. | Chairman | Current |
| Thevanguard.Org | Finance Chairman and Systems Strategist | Current |
| Pacific Telesis | Director | Current |
| SBC Communications, Inc. | Board of Directors | Current |
| American Film Institute | Director | Current |
| SBC Communications, Inc. | Director | Current |
| Sematech | Director | Current |
| Bpm Forum | Board of Directors | Current |
| Pacific Summit Capital | Board of Directors | Current |
| Chiron | Director | Current |
| AT&T Inc. | Board of Directors | Current |
| American Film Institute | Trustee | Current |
| Amtech Corp. | Chief Executive Officer | Former |
| Apple Inc. | CEO | Former |
| National Semiconductor Corporation | CEO | Former |
| Rockwell International Corporation | President | Former |
| National Semiconductor Corporation | President | Former |
| Jazz Technologies, Inc. | Co-Founder | Former |
| Jazz Technologies, Inc. | Chairman and CEO | Current |
| Amtech Corp. | Chairman | Former |
| National Semiconductor Corporation | Chairman | Former |
| Jazz Technologies, Inc. | Board of Directors | Former |
| Georgia Institute of Technology | PhD in physics | Former |
| Georgia Institute of Technology | MS | Former |
| Georgia Institute of Technology | BS | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Galenica Ltd. | Board of Directors | Current |
| Chiron | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | Director | Current |
| Crucell N.V. | Board of Directors | Current |
| Crucell N.V. | Chairman | Former |
| University of Utrecht | PhD | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | Director | Current |
| ICOS Corporation | Director | Current |
| Amylin Pharmaceuticals, Inc. | Director | Current |
| Eli Lilly and Company | CEO | Former |
| Eli Lilly and Company | President | Former |
| Vector Securities International, Inc. | Vice Chairman | Former |
| The University of North Carolina | B.S. Degree In Pharmacy | Former |
| Eli Lilly and Company | member | Former |
Executive News
-
Thoratec Presentation at Baird Conference to be Webcast
Industry Transcripts by Seeking Alpha
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
-
Arena Pharmaceuticals Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ARNA
-
Javelin Pharmaceuticals, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about JAV
-
Alexza Pharmaceuticals, Inc., Q3 2009 Earnings Call Transcript
on Nov 09, 2009about ALXA
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- The 10 Weirdest Drug Stories of the Month 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes


